{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:53:22Z","timestamp":1790409202281,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3748,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1111\/j.1538-7836.2012.04850.x","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T12:33:15Z","timestamp":1342009995000},"page":"1814-1822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII"],"prefix":"10.1016","volume":"10","author":[{"given":"P.","family":"LAPALUD","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"ALI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"CAYZAC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"MATHIEU\u2010DUPAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"LEVESQUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"PFEIFFER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"BALICCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"GRUEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Y.","family":"BORG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"SCHVED","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"GRANIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"LAVIGNE\u2010LISSALDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0046-8177(87)80333-7","article-title":"Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors)","volume":"18","author":"Hoyer","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1615780","article-title":"Biochemistry and physiology of blood coagulation","volume":"82","author":"Mann","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/312337a0","article-title":"Structure of human factor VIII","volume":"312","author":"Vehar","year":"1984","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6807-10-7","article-title":"Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study","volume":"10","author":"Venkateswarlu","year":"2010","journal-title":"BMC Struct Biol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0030","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2\u2010year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Huth\u2010Kuhne","year":"2009","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2008.05.003","article-title":"Laboratory, clinical and therapeutic aspects of acquired hemophilia A","volume":"395","author":"Franchini","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.autrev.2010.11.005","article-title":"Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options","volume":"10","author":"Shetty","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired hemophilia A: a concise review","volume":"80","author":"Franchini","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry","volume":"10","author":"Knoebl","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2516.2001.00506.x","article-title":"Postpartum acquired haemophilia: clinical recognition and management","volume":"7","author":"Kashyap","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ajh.20702","article-title":"Postpartum acquired factor VIII inhibitors","volume":"81","author":"Franchini","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V58.3.619.619","article-title":"Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis","volume":"58","author":"Coller","year":"1981","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<1::AID-AJH1>3.0.CO;2-T","article-title":"Postpartum acquired factor VIII inhibitors: results of a survey","volume":"59","author":"Solymoss","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-0609.1978.tb02434.x","article-title":"Factor VIII inhibitor postpartum","volume":"20","author":"Michiels","year":"1978","journal-title":"Scand J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1651666","article-title":"Post\u2010partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment","volume":"73","author":"Hauser","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0090","first-page":"612","article-title":"Proceedings: A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2516.2008.01924.x","article-title":"Diagnosis and quantification of factor VIII inhibitors","volume":"16","author":"Verbruggen","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/asheducation-2006.1.432","article-title":"Acquired factor VIII inhibitors: pathophysiology and treatment","volume":"1","author":"Ma","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1365-2141.1996.d01-1705.x","article-title":"High incidence of anti\u2010FVIII antibodies against non\u2010coagulant epitopes in haemophilia A patients: a possible role for the half\u2010life of transfused FVIII","volume":"93","author":"Dazzi","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0110","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1160\/TH10-10-0668","article-title":"Prevalence and epitope specificity of non\u2010neutralising antibodies in a large cohort of haemophilia A patients without inhibitors","volume":"105","author":"Lebreton","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0037-1613257","article-title":"Distribution of Th1\u2010 and Th2\u2010induced anti\u2010factor VIII IgG subclasses in congenital and acquired hemophilia patients","volume":"88","author":"Reding","year":"2002","journal-title":"Thromb Haemost"},{"issue":"Suppl 6","key":"10.1111\/j.1538-7836.2012.04850.x_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2006.01363.x","article-title":"Immunological aspects of inhibitor development","volume":"12","author":"Reding","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0049-3848(01)00385-1","article-title":"Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease","volume":"104","author":"Matsumoto","year":"2001","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0130","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1160\/TH07-08-0497","article-title":"Simultaneous detection and epitope mapping of anti\u2010factor VIII antibodies","volume":"99","author":"Lavigne\u2010Lissalde","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0135","doi-asserted-by":"crossref","first-page":"O\u2010M\u2010062","DOI":"10.1111\/j.1538-7836.2007.tb00888.x","article-title":"Epidemiology and one\u2010year outcomes in patients with acquired hemophilia in France. The SACHA prospective project","volume":"5","author":"Borg","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0140","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1016\/S0021-9258(18)31537-0","article-title":"Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1\/A3\u2010C1\u2010C2 dimer and A2 subunit","volume":"266","author":"Fay","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1160\/TH02-09-0086","article-title":"Anti\u2010heavy\u2010chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor","volume":"90","author":"Raut","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1160\/TH06-09-0510","article-title":"Molecular characterization of human B domain\u2010specific anti\u2010factor VIII monoclonal antibodies generated in transgenic mice","volume":"98","author":"Lavigne\u2010Lissalde","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0155","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1073\/pnas.82.22.7728","article-title":"Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments","volume":"82","author":"Fulcher","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0160","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood.V74.5.1618.1618","article-title":"Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization","volume":"74","author":"Scandella","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0165","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1182\/blood.V89.10.3663","article-title":"The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups","volume":"89","author":"Prescott","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jim.2005.10.016","article-title":"Mapping of FVIII inhibitor epitopes using cellulose\u2010bound synthetic peptide arrays","volume":"308","author":"Kopecky","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0175","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1160\/TH08-08-0508","article-title":"Epitope specificity of anti\u2010factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains","volume":"101","author":"Gharagozlou","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0180","first-page":"73","article-title":"Immunochemical characterization of factor VIII inhibitors","volume":"150","author":"Hoyer","year":"1984","journal-title":"Prog Clin Biol Res"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0185","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1182\/blood.V69.5.1475.1475","article-title":"FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting","volume":"69","author":"Fulcher","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0190","first-page":"1","article-title":"Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients","volume":"31","author":"Hoyer","year":"1994","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0195","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2008.07232.x","article-title":"IgG subclasses of anti\u2010FVIII antibodies during immune tolerance induction in patients with hemophilia A","volume":"142","author":"van Helden","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non\u2010hemophilic patients with inhibitors to Factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0205","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9343(98)00289-7","article-title":"Acquired hemophilia due to factor VIII inhibitors in 34 patients","volume":"105","author":"Bossi","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0210","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.1999.01268.x","article-title":"Factor VIII inhibitors in haemophiliacs: a single\u2010centre experience over 34\u2003years, 1964\u201097","volume":"104","author":"Yee","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1471-0528.2003.01535.x","article-title":"Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice","volume":"110","author":"Baudo","year":"2003","journal-title":"BJOG"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1160\/TH05-11-0753","article-title":"Haemostasis and pregnancy","volume":"95","author":"Franchini","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4414\/smw.2010.12597","article-title":"Hormones, immune response, and pregnancy in healthy women and SLE patients","volume":"140","author":"Zen","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0230","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/art.20837","article-title":"Pregnancy, cytokines, and disease activity in systemic lupus erythematosus","volume":"51","author":"Doria","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0889-857X(05)70170-8","article-title":"Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy","volume":"26","author":"Kanik","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0240","first-page":"207","article-title":"The thyroid and autoimmunity","volume":"47","author":"Lichiardopol","year":"2009","journal-title":"Rom J Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04850.x_bb0245","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02786470","article-title":"The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy","volume":"20","author":"Singh","year":"1999","journal-title":"Immunol Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04850.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622064698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622064698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04850.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:02:37Z","timestamp":1761534157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622064698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1538783622064698"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04850.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04850.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}